Noel Frey

Bern, BE 3010, Switzerland

Last Updated: 09/26/2026

Save publications for later

Sign Up

Not sure about your diagnosis?

Check Your Symptoms

Found 9 publications

JAK2 Unmutated Polycythaemia-Real-World Data of 10 Years from a Tertiary Reference Hospital.

JAK2 Unmutated Polycythaemia-Real-World Data of 10 Years from a Tertiary Reference Hospital.

Journal: Journal of clinical medicine

Published: May 16, 2022

Survival after Stevens‒Johnson Syndrome or Toxic Epidermal Necrolysis: A United Kingdom‒Based Cohort Study.

Survival after Stevens‒Johnson Syndrome or Toxic Epidermal Necrolysis: A United Kingdom‒Based Cohort Study.

Journal: The Journal of investigative dermatology

Published: December 04, 2019

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.

Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in Association with Commonly Prescribed Drugs in Outpatient Care Other than Anti-Epileptic Drugs and Antibiotics: A Population-Based Case-Control Study.

Journal: Drug safety

Published: August 17, 2018

Response: The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs: Comment on data sparsity.

Response: The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs: Comment on data sparsity.

Journal: Epilepsia

Published: May 04, 2018

Risk of Incident Osteoarthritis of the Hand in Statin Initiators: A Sequential Cohort Study.

Risk of Incident Osteoarthritis of the Hand in Statin Initiators: A Sequential Cohort Study.

Journal: Arthritis care & research

Published: November 22, 2017

Antibiotic Drug Use and the Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Population-Based Case-Control Study.

Antibiotic Drug Use and the Risk of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis: A Population-Based Case-Control Study.

Journal: The Journal of investigative dermatology

Published: November 01, 2017

The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs.

The risk of Stevens-Johnson syndrome and toxic epidermal necrolysis in new users of antiepileptic drugs.

Journal: Epilepsia

Published: September 22, 2017

The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK.

The Epidemiology of Stevens-Johnson Syndrome and Toxic Epidermal Necrolysis in the UK.

Journal: The Journal of investigative dermatology

Published: December 16, 2016

Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink.

Validation of Stevens-Johnson syndrome or toxic epidermal necrolysis diagnoses in the Clinical Practice Research Datalink.

Journal: Pharmacoepidemiology and drug safety

Published: March 18, 2016

Showing 1-9 of 9

Last Updated: 09/26/2026